Lv1
88 积分 2024-12-23 加入
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
1个月前
已完结
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma
3个月前
已完结
Mechanism of hepatobiliary toxicity of the LPA1 antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: Contrasts with BMS-986234 and BMS-986278
6个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
8个月前
已完结
Evaluation of the patent portfolio for helicase-primase inhibitor ABI-5366 of Assembly biosciences inc
8个月前
已完结
Correlated Motions and Dynamics in Different Domains of Epidermal Growth Factor Receptor With L858R and T790M Mutations
8个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
8个月前
已完结
First phase 3 trial of GLP-1 receptor agonist for neurodegeneration
10个月前
已完结
皖公网安备34019202002308
